Mill Capital Management’s Quest Diagnostics DGX Stock Holding History

Mill Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$378K	Hold	1,620	–	–	0.02%	101
2026 Q2	$343K	Hold	1,620	–	–	0.02%	106
2026 Q1	$317K	Hold	1,620	–	–	0.02%	105
2025 Q4	$281K	Hold	1,620	–	–	0.02%	111
2025 Q3	$309K	Hold	1,620	–	–	0.02%	106
2025 Q2	$291K	Hold	1,620	–	–	0.02%	106
2025 Q1	$274K	Hold	1,620	–	–	0.02%	106
2024 Q4	$244K	Hold	1,620	–	–	0.02%	108
2024 Q3	$252K	Sell	1,620 -188	-10%	-$28.1K	0.02%	107
2024 Q2	$247K	Hold	1,808	–	–	0.02%	105
2024 Q1	$241K	Hold	1,808	–	–	0.02%	106
2023 Q4	$249K	Sell	1,808 -125	-6%	-$16.4K	0.02%	104
2023 Q3	$236K	Hold	1,933	–	–	0.02%	105
2023 Q2	$272K	Hold	1,933	–	–	0.03%	105
2023 Q1	$273K	Hold	1,933	–	–	0.03%	112
2022 Q4	$302K	Hold	1,933	–	–	0.03%	106
2022 Q3	$237K	Hold	1,933	–	–	0.03%	109
2022 Q2	$257K	Hold	1,933	–	–	0.03%	112
2022 Q1	$265K	Hold	1,933	–	–	0.03%	117
2021 Q4	$334K	Buy	+1,933	New	+$294K	0.03%	99

Other funds holding DGX

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Conning Inc Hartford, Connecticut $3.25B AUM 18.91% 1-Year Est. Return

Cookson Peirce & Co Pittsburgh, Pennsylvania $2.77B AUM 64.09% 1-Year Est. Return

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return

Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Mill Capital Management's DGX Position: Q3 2026 in Review

Mill Capital Management held its Quest Diagnostics (DGX) position steady in Q3 2026 at 1,620 shares worth $378K. The position accounts for 0.02% of the portfolio, ranked #101.

Mill Capital Management first reported a position in DGX in Q4 2021 and has held it in 20 quarters since. 417 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

Mill Capital Management held 1,620 shares of Quest Diagnostics worth $378K as of Q3 2026.
Mill Capital Management left its Quest Diagnostics share count unchanged in Q3 2026.
Quest Diagnostics made up 0.02% of Mill Capital Management's portfolio in Q3 2026, its #101 holding.
Mill Capital Management first reported a position in Quest Diagnostics in Q4 2021 and has held it in 20 quarters since.
417 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Mill Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.